Security key
75383L102
Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)
CUSIP: 75383L102
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 47,779,015
- Total 13F shares
- 36,577,539
- Share change
- +24,647
- Total reported value
- $648,890,836
- Price per share
- $17.74
- Number of holders
- 69
- Value change
- -$29,671
- Number of buys
- 33
- Number of sells
- 18
Report period
Q4 2024
Institutions
69
Top holders
10
RAPP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Rapport Therapeutics, Inc. SEC filings
Rapport Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75383L102
Recent filing periods:
Ownership snapshot
Top shareholders of RAPP - Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Third Rock Ventures V, L.P.
13D/G signal
Third Rock Ventures V, L.P.
Evidence rows
50
Latest as of
31 Dec 2024
13D/G
13F
Lead comparable stake: 20%
13D/G row: Third Rock Ventures V, L.P.
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. |
13D/G
|
20%
|
$81,198,952
7,135,233 shares
|
$0 | 31 Dec 2024 |
| FMR LLC |
13F
Company
|
11%
|
$112,362,864
5,486,468 shares
|
— | 30 Sep 2024 |
| ARCH Venture Management, LLC |
13F
Company
|
7.8%
|
$76,364,554
3,728,738 shares
|
— | 30 Sep 2024 |
| Cormorant Asset Management, LP |
13F
Company
|
6.2%
|
$60,230,062
2,940,921 shares
|
— | 30 Sep 2024 |
| Capital International Investors |
13F
Company
|
5.4%
|
$53,299,794
2,602,529 shares
|
— | 30 Sep 2024 |
| JOHNSON & JOHNSON |
13F
Company
|
5.2%
|
$51,160,084
2,498,051 shares
|
— | 30 Sep 2024 |
| Sofinnova Investments, Inc. |
13F
Company
|
4.2%
|
$40,869,765
1,995,594 shares
|
— | 30 Sep 2024 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
3.6%
|
$35,372,000
1,727,111 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
69
Shares
36,577,539
Rows loaded
69
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
55
Q4 2024 holders
69
Holder diff
14
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend